intravenous formulation

Related by string. intravenous formulations * intra venous . Intravenous : intravenous drips dangling . intravenous drip . intravenous antibiotics . intravenous drips / Formulation . Formulations . formulations : inhaled formulation . proprietary formulation . injectable formulation * proprietary intravenous formulation . investigational FACTIVE intravenous formulation *

Related by context. Frequent words. (Click for all words.) 66 oral formulation 65 injectable formulation 65 ecallantide 64 investigational drug 63 Zerenex 63 Dyloject 62 methylnaltrexone 61 Ventavis 61 Staccato loxapine 61 orally administered 60 Horizant 60 Rivaroxaban 60 adjunctive treatment 59 PROMACTA 59 Ceftobiprole 59 ocular hypertension 59 BAY #-# 59 ONSOLIS 59 MBP# [001] 59 SILENOR TM 59 Renvela 59 Phase 2b study 59 VPRIV 59 prodrug 59 investigational oral 59 Ceplene 59 TREANDA 59 tablet formulation 59 investigational compound 58 Entereg 58 Marketing Authorization Application MAA 58 Phase III clinical 58 Phase 2b clinical 58 chronic angina 58 Intermezzo R 58 Phase 2a trial 58 adjunctive therapy 58 fidaxomicin 58 JANUVIA 58 OFIRMEV 58 Fodosine TM 58 Phase IIb clinical 58 PhosLo 58 relapsed multiple myeloma 58 Adlea 57 CoFactor 57 lubiprostone 57 daclizumab 57 VIMOVO 57 linaclotide 57 tamibarotene 57 Cimzia ® 57 eltrombopag 57 opioid induced constipation 57 Phase IIa trial 57 oncology indications 57 phase IIa 57 retigabine 57 Phase 2a clinical 57 Bronchitol 57 ADX# 57 diabetic neuropathic pain 57 FOSRENOL 57 Torisel 56 ATryn R 56 APF# 56 crofelemer 56 ceftaroline 56 taliglucerase alfa 56 NUVIGIL 56 Phase Ib 56 Phase 2b trial 56 biologic therapy 56 NGX# 56 PEG INTRON 56 ONCONASE 56 ambrisentan 56 pivotal Phase III 56 ZADAXIN 56 voclosporin 56 FOLOTYN 56 Phase 2a 56 LIALDA 56 Amigal 56 Phase III clinical trials 56 Phase IIa 56 DAVANAT R 56 adjunct therapy 56 vandetanib 56 opioid analgesic 55 TORISEL 55 oritavancin 55 orally bioavailable 55 inhaled corticosteroid 55 Marketing Authorization Application 55 POSIDUR 55 Peramivir 55 Phase IIa clinical 55 Trexima 55 Amitiza 55 Everolimus

Back to home page